Anticoagulation in atrial fibrillation with factor X deficiency—A management dilemma

Factor X (FX) deficiency is a rare bleeding disorder. There is currently no clear guideline or recommendation for the appropriate selection of anticoagulation and management of patients with FX deficiency who require anticoagulation. We shared our experience in managing such patient, and we further...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Jian Liang, Loh, Kah Poh, Fortuna, Danielle, Ghaneie, Arezoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132141/
https://www.ncbi.nlm.nih.gov/pubmed/30214763
http://dx.doi.org/10.1002/ccr3.1731
_version_ 1783354264684331008
author Tan, Jian Liang
Loh, Kah Poh
Fortuna, Danielle
Ghaneie, Arezoo
author_facet Tan, Jian Liang
Loh, Kah Poh
Fortuna, Danielle
Ghaneie, Arezoo
author_sort Tan, Jian Liang
collection PubMed
description Factor X (FX) deficiency is a rare bleeding disorder. There is currently no clear guideline or recommendation for the appropriate selection of anticoagulation and management of patients with FX deficiency who require anticoagulation. We shared our experience in managing such patient, and we further discussed other possible treatment options.
format Online
Article
Text
id pubmed-6132141
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-61321412018-09-13 Anticoagulation in atrial fibrillation with factor X deficiency—A management dilemma Tan, Jian Liang Loh, Kah Poh Fortuna, Danielle Ghaneie, Arezoo Clin Case Rep Case Reports Factor X (FX) deficiency is a rare bleeding disorder. There is currently no clear guideline or recommendation for the appropriate selection of anticoagulation and management of patients with FX deficiency who require anticoagulation. We shared our experience in managing such patient, and we further discussed other possible treatment options. John Wiley and Sons Inc. 2018-07-22 /pmc/articles/PMC6132141/ /pubmed/30214763 http://dx.doi.org/10.1002/ccr3.1731 Text en © 2018 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Tan, Jian Liang
Loh, Kah Poh
Fortuna, Danielle
Ghaneie, Arezoo
Anticoagulation in atrial fibrillation with factor X deficiency—A management dilemma
title Anticoagulation in atrial fibrillation with factor X deficiency—A management dilemma
title_full Anticoagulation in atrial fibrillation with factor X deficiency—A management dilemma
title_fullStr Anticoagulation in atrial fibrillation with factor X deficiency—A management dilemma
title_full_unstemmed Anticoagulation in atrial fibrillation with factor X deficiency—A management dilemma
title_short Anticoagulation in atrial fibrillation with factor X deficiency—A management dilemma
title_sort anticoagulation in atrial fibrillation with factor x deficiency—a management dilemma
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132141/
https://www.ncbi.nlm.nih.gov/pubmed/30214763
http://dx.doi.org/10.1002/ccr3.1731
work_keys_str_mv AT tanjianliang anticoagulationinatrialfibrillationwithfactorxdeficiencyamanagementdilemma
AT lohkahpoh anticoagulationinatrialfibrillationwithfactorxdeficiencyamanagementdilemma
AT fortunadanielle anticoagulationinatrialfibrillationwithfactorxdeficiencyamanagementdilemma
AT ghaneiearezoo anticoagulationinatrialfibrillationwithfactorxdeficiencyamanagementdilemma

Ejemplares similares